Top 10 Books about Stock Investing to read in 2018. Read more.

IOVA - Iovance Biotherapeutics, Inc.

IOVA - Iovance Biotherapeutics, Inc.


Thu 15'th Feb 2018

PERIOD 2017-11-16 - 2018-02-15
CHANGE 0.00%
PRICE $17.40






Iovance Biotherapeutics, Inc. Stock Analysis

Technical stock analysis for Thu 15'th Feb 2018

Shorts 3.26% ( 2018-01-31 )
Cash 606.1 mill
Loans n/a
Beta 2.08
ROA -44.95
Buy candidate since 2018-01-10 Gain 102.33%

No changes to the price of Iovance Biotherapeutics, Inc. in the last trading day. The price has risen in 5 of the last 10 days and is up by 5.45% over the past 2 weeks.

Access today's Top 5 Buy Candidates


Iovance Biotherapeutics, Inc. lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $17.55 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 110.61% during the next 3 months and, with 90% probability hold a price between $27.99 and $36.96 at the end of this period.

Click here for today's Top 5 Trending Companies


Iovance Biotherapeutics, Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $16.93 and $12.35. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday February 14, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention for the next couple of days.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 79 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $16.50 and $14.65. There is no resistance from accumulated volume above today's level and given the right condition the stock may perform very well during the next couple of days.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Iovance Biotherapeutics, Inc. finds support just below today's level at $16.50. If this is broken, then the next support from accumulated volume will be at $14.65 and $13.70.

Support: $16.50 Price: $17.40


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.70 between high and low, or 4.14%. For the last week, the stock has had a daily average volatility of 7.20%.

The stock is overbought on RSI14 and lies in the upper part of the trend. Normally this will pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stoploss: $16.48 (-5.31%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 79 and this increases the risk substantially. There is a sell signal from pivot top found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Trade IOVA CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).